AETAS Pharma None
AETAS Pharma is a pharmaceutical company focused on research and development, with a particular emphasis on improving cardiac and renal functions. They are currently developing a therapeutic agent for atrial fibrillation in heart disease, which has yet to have a definitive treatment. The company was established in May 2000 and has been dedicated to drug discovery research and development since then.
Headquarters:
Tokyo, Tokyo, Japan
Estimated Revenue:
$384. 00 million